JP2023500875A5 - - Google Patents
Info
- Publication number
- JP2023500875A5 JP2023500875A5 JP2022525715A JP2022525715A JP2023500875A5 JP 2023500875 A5 JP2023500875 A5 JP 2023500875A5 JP 2022525715 A JP2022525715 A JP 2022525715A JP 2022525715 A JP2022525715 A JP 2022525715A JP 2023500875 A5 JP2023500875 A5 JP 2023500875A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- cancer
- drug conjugate
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962932373P | 2019-11-07 | 2019-11-07 | |
| US62/932,373 | 2019-11-07 | ||
| PCT/IB2020/000917 WO2021090062A1 (en) | 2019-11-07 | 2020-11-06 | Anti-mesothelin eribulin antibody-drug conjugates and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023500875A JP2023500875A (ja) | 2023-01-11 |
| JP2023500875A5 true JP2023500875A5 (cg-RX-API-DMAC7.html) | 2023-11-08 |
| JP7657213B2 JP7657213B2 (ja) | 2025-04-04 |
Family
ID=73943294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525715A Active JP7657213B2 (ja) | 2019-11-07 | 2020-11-06 | 抗メソテリンエリブリン抗体-薬物コンジュゲート及び使用方法 |
Country Status (17)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119405833A (zh) | 2018-06-01 | 2025-02-11 | 卫材R&D管理有限公司 | 剪接调节抗体-药物缀合物及其使用方法 |
| IL278740B2 (en) | 2018-06-01 | 2024-01-01 | Eisai R&D Man Co Ltd | Methods for using splicing modulators |
| CN120189526A (zh) | 2018-12-13 | 2025-06-24 | 卫材R&D管理有限公司 | 荷伯希二烯抗体-药物缀合物及使用方法 |
| WO2021090062A1 (en) | 2019-11-07 | 2021-05-14 | Eisai R&D Management Co., Ltd. | Anti-mesothelin eribulin antibody-drug conjugates and methods of use |
| EP4161966A1 (en) | 2020-06-05 | 2023-04-12 | Eisai R&D Management Co., Ltd. | Anti-bcma antibody-drug conjugates and methods of use |
| MX2024000893A (es) * | 2021-07-22 | 2024-02-06 | Shanghai Senhui Medicine Co Ltd | Farmaco conjugado de un derivado de eribulina. |
| EP4385522A1 (en) * | 2021-08-13 | 2024-06-19 | Kunshan Xinyunda Biotech Co., Ltd. | Microtubule inhibitor-based antibody-drug conjugate |
| IL311324A (en) * | 2021-09-16 | 2024-05-01 | Chia Tai Tianqing Pharmaceutical Group Co Ltd | A drug-antibody conjugate against HER3, a preparation including it and its use |
| TW202321296A (zh) | 2021-10-06 | 2023-06-01 | 美商鏈接免疫療法公司 | 抗間皮素抗原結合分子及其用途 |
| CN122349614A (zh) * | 2023-10-13 | 2026-07-07 | 卫材R&D管理有限公司 | 抗体-药物缀合物代谢物 |
| WO2026039642A1 (en) * | 2024-08-16 | 2026-02-19 | Ardeagen Corporation | Anti-mesothelin antibody conjugates and methods of use thereof |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4880078A (en) | 1987-06-29 | 1989-11-14 | Honda Giken Kogyo Kabushiki Kaisha | Exhaust muffler |
| FI903489A7 (fi) | 1988-11-11 | 1990-07-10 | Medical Res Council | Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö |
| JPH06507404A (ja) | 1991-05-01 | 1994-08-25 | ヘンリー エム.ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン | 感染性の呼吸性疾患の治療方法 |
| US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
| US6019968A (en) | 1995-04-14 | 2000-02-01 | Inhale Therapeutic Systems, Inc. | Dispersible antibody compositions and methods for their preparation and use |
| US5985320A (en) | 1996-03-04 | 1999-11-16 | The Penn State Research Foundation | Materials and methods for enhancing cellular internalization |
| US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| DE69732306T2 (de) | 1997-01-16 | 2006-01-12 | Massachusetts Institute Of Technology, Cambridge | Zubereitung von partikelhaltigen arzneimitteln zur inhalation |
| CA2632433C (en) | 1998-06-17 | 2012-02-07 | Eisai R & D Management Co., Ltd. | Methods for preparing macrocyclic analogs and intermediates for preparing same |
| US6653341B1 (en) | 1998-06-17 | 2003-11-25 | Eisai Co., Ltd. | Methods and compositions for use in treating cancer |
| ES2198922T3 (es) | 1998-06-24 | 2004-02-01 | Advanced Inhalation Research, Inc. | Particulas porosas grandes emitadas por un inhalador. |
| US9416190B2 (en) * | 2012-09-27 | 2016-08-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Mesothelin antibodies and methods for eliciting potent antitumor activity |
| TWI700298B (zh) * | 2015-04-13 | 2020-08-01 | 美商輝瑞股份有限公司 | 靶向b細胞成熟抗原之嵌合型抗原受體類 |
| EP3795591B1 (en) | 2015-06-19 | 2023-09-27 | Eisai R&D Management Co., Ltd. | Cys80 conjugated immunoglobulins |
| EP4032902A1 (en) | 2015-12-18 | 2022-07-27 | Eisai R&D Management Co., Ltd. | C-terminal lysine conjugated immunoglobulins |
| WO2017136769A1 (en) | 2016-02-04 | 2017-08-10 | Eisai R&D Management Co., Ltd. | Peptide drug conjugates |
| MY199595A (en) * | 2016-03-02 | 2023-11-08 | Eisai R&D Man Co Ltd | Eribulin-based antibody-drug conjugates and methods of use |
| CN119405833A (zh) | 2018-06-01 | 2025-02-11 | 卫材R&D管理有限公司 | 剪接调节抗体-药物缀合物及其使用方法 |
| CN120189526A (zh) | 2018-12-13 | 2025-06-24 | 卫材R&D管理有限公司 | 荷伯希二烯抗体-药物缀合物及使用方法 |
| WO2021090062A1 (en) | 2019-11-07 | 2021-05-14 | Eisai R&D Management Co., Ltd. | Anti-mesothelin eribulin antibody-drug conjugates and methods of use |
| JP7821733B2 (ja) | 2020-01-22 | 2026-02-27 | 上海森輝医薬有限公司 | エリブリン誘導体の薬物複合体、その調製方法及びその医薬的応用 |
| EP4161966A1 (en) | 2020-06-05 | 2023-04-12 | Eisai R&D Management Co., Ltd. | Anti-bcma antibody-drug conjugates and methods of use |
-
2020
- 2020-11-06 WO PCT/IB2020/000917 patent/WO2021090062A1/en not_active Ceased
- 2020-11-06 EP EP20828836.5A patent/EP4055053A1/en active Pending
- 2020-11-06 AU AU2020380603A patent/AU2020380603A1/en active Pending
- 2020-11-06 CN CN202080076659.9A patent/CN114729042B/zh active Active
- 2020-11-06 US US17/091,819 patent/US11572414B2/en active Active
- 2020-11-06 TW TW109138938A patent/TWI877249B/zh active
- 2020-11-06 KR KR1020227016852A patent/KR20220095197A/ko active Pending
- 2020-11-06 JP JP2022525715A patent/JP7657213B2/ja active Active
- 2020-11-06 PH PH1/2022/551036A patent/PH12022551036A1/en unknown
- 2020-11-06 CA CA3159541A patent/CA3159541A1/en active Pending
- 2020-11-06 MX MX2022005221A patent/MX2022005221A/es unknown
- 2020-11-06 MY MYPI2022002370A patent/MY209745A/en unknown
- 2020-11-06 PE PE2022000738A patent/PE20230467A1/es unknown
- 2020-11-06 BR BR112022008756A patent/BR112022008756A2/pt active Search and Examination
-
2022
- 2022-03-17 JO JOP/2022/0070A patent/JOP20220070A1/ar unknown
- 2022-03-23 IL IL291643A patent/IL291643A/en unknown
- 2022-06-03 CO CONC2022/0007924A patent/CO2022007924A2/es unknown
- 2022-12-23 US US18/146,246 patent/US12564641B2/en active Active